Tags : Horizon

Top 20 Immunology Companies Based 2019 Immunology Segment Revenue

Immunology is an important branch of science which deals with the study of the immune system. The immune system is a highly regulated and balanced system and when the balance is disturbed, the disease can result. A lot of this work has importance in the development of new therapies and treatments that can handle or […]Read More

Insights+: Novel Approvals of February 2020

The US FDA has approved multiple NDAs and BLAs in Feb 2020, leading to treatments for patients and advances in health care. The Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 13 novel products so far in 2020, including 10 in Feb and 3 in Jan […]Read More

Horizon’s Procysbi (Cysteamine Bitartrate) Receives the US FDA’s Approval for

Shots: The US FDA has approved Procysbi for adults and children one year of age and older living with nephropathic cystinosis Procysbi (cysteamine bitartrate) is a delayed-release capsules and delayed-release oral granules also a cystine-depleting agent indicated to treat nephropathic cystinosis in adults and pediatric patients 1 year of age and older Procysbi will continue […]Read More